Lavelle Capital’s Cardinal Health CAH Stock Holding History

Lavelle Capital’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,715	Closed	-$352K	–	76
2025 Q4	$352K	Buy	+1,715	New	+$323K	0.22%	74

Other funds holding CAH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Lavelle Capital's CAH Position: Q1 2026 in Review

Lavelle Capital sold out of Cardinal Health (CAH) in Q1 2026, closing a stake of 1,715 shares — an estimated $352K sold.

Lavelle Capital first reported a position in CAH in Q4 2025 and held it in 1 quarter. The position peaked at $352K in Q4 2025. 1,435 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

Lavelle Capital reported no remaining Cardinal Health position as of Q1 2026 after selling out during the quarter.
Lavelle Capital sold 1,715 Cardinal Health shares in Q1 2026, an estimated $352K.
Lavelle Capital first reported a position in Cardinal Health in Q4 2025 and held it in 1 quarter.
Lavelle Capital's Cardinal Health position peaked at $352K in Q4 2025.
1,435 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on Lavelle Capital's 13F filing for Q1 2026, filed 28 May 2026.